AI assistant
Sending…
Replimune Group, Inc. — Director's Dealing 2024
Nov 21, 2024
33193_dirs_2024-11-20_49d13e91-6a58-4e0f-8391-666755811c02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2024-11-18
Reporting Person: Sarchi Christopher (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-18 | Common Stock | S | 5207 | $10.78 | Disposed | 87045 | Direct |
Footnotes
F1: Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.
More from Replimune Group, Inc.
Director's Dealing
2026
Feb 20
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19
Director's Dealing
2025
Dec 19